Besides a well-known biomarker for adenocarcinoma, the serum CEA was also correlated with the severity of idiopathic pulmonary fibrosis (39–41) and serves as a powerful indicator of RP-ILD and poor prognosis in patients with CADM (42). The gene discussed is CEACAM5; the disease is interstitial lung disease.